SELECTIVE TARGETING OF FCRN AND IGG CLEARANCE BY NIPOCALIMAB PRESERVES KEY IMMUNE FUNCTIONS LE Ling; S Tyler; CJ Beneduce; F Yu; J Brown; S Kumar; R Xu; J Duffner; AB Perdomo; W Avery;

EFFICACY AND SAFETY OF NIPOCALIMAB, AN FCRN BLOCKER, IN WARM AUTOIMMUNE HEMOLYTIC ANEMIA (WAIHA): ENERGY PHASE 2/3 STUDY DESIGN I Murakhovskaya; B Fattizzo; D Cueto; AB Perdomo; M Jouvin;